Physician profile
Luke Kennedy
NPI 1427679745
$1,807.37
in general payments reported to CMS, 2019-2025
9 companies · $1,654 in 2025
The $1,654 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $153 · 2025: $1,654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,206 · Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,205.84 |
| Food and Beverage | $601.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,478.23 | 2025 | Spyglass, Captivator II, Exalt Model D |
| Ardelyx, INC. | $120.93 | 2024 | Ibsrela |
| Madrigal Pharmaceuticals | $45.29 | 2025 | Rezdiffra |
| Olympus America INC. | $34.67 | 2025 | Evis Exera III Colonovideoscope |
| Mallinckrodt Hospital Products INC. | $31.97 | 2024 | Terlivaz |
| Aimmune Therapeutics, INC. | $29.03 | 2025 | Zenpep |
| Abbvie INC. | $26.15 | 2025 | |
| Enterra Medical, INC. | $20.56 | 2025 | |
| Medtronic, INC. | $20.54 | 2025 | Pillcam |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Kennedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.